United States PDE Inhibitors Market Report 2018

March 2018 | 102 pages | ID: U417ADD9DC4EN
QYResearch

Abstracts

In this report, the United States PDE Inhibitors market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of PDE Inhibitors in these regions, from 2013 to 2025 (forecast).

United States PDE Inhibitors market competition by top manufacturers/players, with PDE Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Hanmi Science Holding
• Boehringer Ingelheim
• Takeda Pharmaceuticals
• Pfizer
• Omeros
• Anacor Pharmaceuticals
• Otsuka
• Chiesi Farmaceutici
• Verona Pharma
• NuSirt Biopharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PDE5
• PDE4
• Viagra
• Cialis
• Levitra
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genitourinary
• Cardiovascular Diseases
• Neurological Diseases
• Dermatological Disorders
• Respiratory Diseases
• Other Indications

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States PDE Inhibitors Market Report 2018

1 PDE INHIBITORS OVERVIEW

1.1 Product Overview and Scope of PDE Inhibitors
1.2 Classification of PDE Inhibitors by Product Category
  1.2.1 United States PDE Inhibitors Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States PDE Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 PDE5
  1.2.4 PDE4
  1.2.5 Viagra
  1.2.6 Cialis
  1.2.7 Levitra
  1.2.8 Others
1.3 United States PDE Inhibitors Market by Application/End Users
  1.3.1 United States PDE Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Genitourinary
  1.3.3 Cardiovascular Diseases
  1.3.4 Neurological Diseases
  1.3.5 Dermatological Disorders
  1.3.6 Respiratory Diseases
  1.3.7 Other Indications
1.4 United States PDE Inhibitors Market by Region
  1.4.1 United States PDE Inhibitors Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West PDE Inhibitors Status and Prospect (2013-2025)
  1.4.3 Southwest PDE Inhibitors Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic PDE Inhibitors Status and Prospect (2013-2025)
  1.4.5 New England PDE Inhibitors Status and Prospect (2013-2025)
  1.4.6 The South PDE Inhibitors Status and Prospect (2013-2025)
  1.4.7 The Midwest PDE Inhibitors Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of PDE Inhibitors (2013-2025)
  1.5.1 United States PDE Inhibitors Sales and Growth Rate (2013-2025)
  1.5.2 United States PDE Inhibitors Revenue and Growth Rate (2013-2025)

2 UNITED STATES PDE INHIBITORS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States PDE Inhibitors Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States PDE Inhibitors Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States PDE Inhibitors Average Price by Players/Suppliers (2013-2018)
2.4 United States PDE Inhibitors Market Competitive Situation and Trends
  2.4.1 United States PDE Inhibitors Market Concentration Rate
  2.4.2 United States PDE Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers PDE Inhibitors Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PDE INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States PDE Inhibitors Sales and Market Share by Region (2013-2018)
3.2 United States PDE Inhibitors Revenue and Market Share by Region (2013-2018)
3.3 United States PDE Inhibitors Price by Region (2013-2018)

4 UNITED STATES PDE INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States PDE Inhibitors Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States PDE Inhibitors Revenue and Market Share by Type (2013-2018)
4.3 United States PDE Inhibitors Price by Type (2013-2018)
4.4 United States PDE Inhibitors Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PDE INHIBITORS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States PDE Inhibitors Sales and Market Share by Application (2013-2018)
5.2 United States PDE Inhibitors Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PDE INHIBITORS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Hanmi Science Holding
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 PDE Inhibitors Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
  6.2.2 PDE Inhibitors Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceuticals
  6.3.2 PDE Inhibitors Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 PDE Inhibitors Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Omeros
  6.5.2 PDE Inhibitors Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Omeros PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Anacor Pharmaceuticals
  6.6.2 PDE Inhibitors Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Otsuka
  6.7.2 PDE Inhibitors Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Chiesi Farmaceutici
  6.8.2 PDE Inhibitors Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Verona Pharma
  6.9.2 PDE Inhibitors Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 NuSirt Biopharma
  6.10.2 PDE Inhibitors Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 PDE INHIBITORS MANUFACTURING COST ANALYSIS

7.1 PDE Inhibitors Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of PDE Inhibitors

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 PDE Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PDE INHIBITORS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States PDE Inhibitors Sales Volume, Revenue Forecast (2018-2025)
11.2 United States PDE Inhibitors Sales Volume Forecast by Type (2018-2025)
11.3 United States PDE Inhibitors Sales Volume Forecast by Application (2018-2025)
11.4 United States PDE Inhibitors Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of PDE Inhibitors
Figure United States PDE Inhibitors Market Size (K Units) by Type (2013-2025)
Figure United States PDE Inhibitors Sales Volume Market Share by Type (Product Category) in 2017
Figure PDE5 Product Picture
Figure PDE4 Product Picture
Figure Viagra Product Picture
Figure Cialis Product Picture
Figure Levitra Product Picture
Figure Others Product Picture
Figure United States PDE Inhibitors Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of PDE Inhibitors by Application in 2017
Figure Genitourinary Examples
Table Key Downstream Customer in Genitourinary
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Neurological Diseases Examples
Table Key Downstream Customer in Neurological Diseases
Figure Dermatological Disorders Examples
Table Key Downstream Customer in Dermatological Disorders
Figure Respiratory Diseases Examples
Table Key Downstream Customer in Respiratory Diseases
Figure Other Indications Examples
Table Key Downstream Customer in Other Indications
Figure United States PDE Inhibitors Market Size (Million USD) by Region (2013-2025)
Figure The West PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States PDE Inhibitors Sales (K Units) and Growth Rate (2013-2025)
Figure United States PDE Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States PDE Inhibitors Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States PDE Inhibitors Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States PDE Inhibitors Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States PDE Inhibitors Sales Share by Players/Suppliers
Figure 2017 United States PDE Inhibitors Sales Share by Players/Suppliers
Figure United States PDE Inhibitors Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States PDE Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States PDE Inhibitors Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States PDE Inhibitors Revenue Share by Players/Suppliers
Figure 2017 United States PDE Inhibitors Revenue Share by Players/Suppliers
Table United States Market PDE Inhibitors Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market PDE Inhibitors Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States PDE Inhibitors Market Share of Top 3 Players/Suppliers
Figure United States PDE Inhibitors Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers PDE Inhibitors Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers PDE Inhibitors Product Category
Table United States PDE Inhibitors Sales (K Units) by Region (2013-2018)
Table United States PDE Inhibitors Sales Share by Region (2013-2018)
Figure United States PDE Inhibitors Sales Share by Region (2013-2018)
Figure United States PDE Inhibitors Sales Market Share by Region in 2017
Table United States PDE Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States PDE Inhibitors Revenue Share by Region (2013-2018)
Figure United States PDE Inhibitors Revenue Market Share by Region (2013-2018)
Figure United States PDE Inhibitors Revenue Market Share by Region in 2017
Table United States PDE Inhibitors Price (USD/Unit) by Region (2013-2018)
Table United States PDE Inhibitors Sales (K Units) by Type (2013-2018)
Table United States PDE Inhibitors Sales Share by Type (2013-2018)
Figure United States PDE Inhibitors Sales Share by Type (2013-2018)
Figure United States PDE Inhibitors Sales Market Share by Type in 2017
Table United States PDE Inhibitors Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States PDE Inhibitors Revenue Share by Type (2013-2018)
Figure Revenue Market Share of PDE Inhibitors by Type (2013-2018)
Figure Revenue Market Share of PDE Inhibitors by Type in 2017
Table United States PDE Inhibitors Price (USD/Unit) by Types (2013-2018)
Figure United States PDE Inhibitors Sales Growth Rate by Type (2013-2018)
Table United States PDE Inhibitors Sales (K Units) by Application (2013-2018)
Table United States PDE Inhibitors Sales Market Share by Application (2013-2018)
Figure United States PDE Inhibitors Sales Market Share by Application (2013-2018)
Figure United States PDE Inhibitors Sales Market Share by Application in 2017
Table United States PDE Inhibitors Sales Growth Rate by Application (2013-2018)
Figure United States PDE Inhibitors Sales Growth Rate by Application (2013-2018)
Table Hanmi Science Holding Basic Information List
Table Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hanmi Science Holding PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Hanmi Science Holding PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Hanmi Science Holding PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceuticals PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceuticals PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceuticals PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Pfizer PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Pfizer PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Omeros Basic Information List
Table Omeros PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Omeros PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Omeros PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Omeros PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Anacor Pharmaceuticals Basic Information List
Table Anacor Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Anacor Pharmaceuticals PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Anacor Pharmaceuticals PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Anacor Pharmaceuticals PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Otsuka Basic Information List
Table Otsuka PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Otsuka PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Otsuka PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Otsuka PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Chiesi Farmaceutici Basic Information List
Table Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Chiesi Farmaceutici PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Chiesi Farmaceutici PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Chiesi Farmaceutici PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Verona Pharma Basic Information List
Table Verona Pharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Verona Pharma PDE Inhibitors Sales Growth Rate (2013-2018)
Figure Verona Pharma PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure Verona Pharma PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table NuSirt Biopharma Basic Information List
Table NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NuSirt Biopharma PDE Inhibitors Sales Growth Rate (2013-2018)
Figure NuSirt Biopharma PDE Inhibitors Sales Market Share in United States (2013-2018)
Figure NuSirt Biopharma PDE Inhibitors Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PDE Inhibitors
Figure Manufacturing Process Analysis of PDE Inhibitors
Figure PDE Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of PDE Inhibitors Major Players/Suppliers in 2017
Table Major Buyers of PDE Inhibitors
Table Distributors/Traders List
Figure United States PDE Inhibitors Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States PDE Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States PDE Inhibitors Price (USD/Unit) Trend Forecast (2018-2025)
Table United States PDE Inhibitors Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States PDE Inhibitors Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States PDE Inhibitors Sales Volume (K Units) Forecast by Type in 2025
Table United States PDE Inhibitors Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States PDE Inhibitors Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States PDE Inhibitors Sales Volume (K Units) Forecast by Application in 2025
Table United States PDE Inhibitors Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States PDE Inhibitors Sales Volume Share Forecast by Region (2018-2025)
Figure United States PDE Inhibitors Sales Volume Share Forecast by Region (2018-2025)
Figure United States PDE Inhibitors Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources